BMY
NYSEStockBristol-Myers Squibb Company
$59.27-0.70 (-1.17%)
52-Week Range
$42.60
$62.37
Key Stats
Market Cap
120.7B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.27
Volume
5.9M
Avg Volume
12.8M
Performance
1M
-1.45%
3M
+14.44%
6M
+29.41%
YTD
+12.20%
1Y
+0.28%
3Y
-9.12%
5Y
-2.30%
Price Chart
ETF Exposure
BMY is held by 434 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 7.49% |
| RDIV | Invesco S&P Ultra Dividend Revenue ETF | 5.49% |
| MEDX | Horizon Kinetics Medical ETF | 4.97% |
| IHE | iShares U.S. Pharmaceuticals ETF | 4.96% |
| PPH | VanEck Pharmaceutical ETF | 4.93% |
| STLC | iShares Trust - iShares Factors US Blend Style ETF | 4.89% |
| BAMV | Brookstone Value Stock ETF | 4.39% |
| SCHD | Schwab U.S. Dividend Equity ETF | 4.26% |
| XUDV | Franklin US Dividend Booster Index ETF | 4.13% |
| SEIQ | SEI Enhanced U.S. Large Cap Quality Factor ETF | 3.72% |
| LNGR | Global X Aging Population ETF | 3.56% |
| CANC | Tema Oncology ETF | 3.54% |
| FDL | First Trust Morningstar Dividend Leaders Index Fund | 3.41% |
| CNCR | Loncar Cancer Immunotherapy ETF | 3.39% |
| JDOC | JPMorgan Healthcare Leaders ETF | 3.39% |
| HDIV | QRAFT AI-Enhanced U.S. High Dividend ETF | 3.22% |
| CAMX | Cambiar Aggressive Value ETF | 3.18% |
| HART | NYLI Healthy Hearts ETF | 3.14% |
| MOAT | VanEck Morningstar Wide Moat ETF | 3.07% |
| PJP | Invesco Pharmaceuticals ETF | 2.84% |
| VALQ | American Century STOXX U.S. Quality Value ETF | 2.67% |
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 2.67% |
| GNOM | Global X - Genomics & Biotechnology ETF | 2.66% |
| ABFL | Abacus FCF Leaders ETF | 2.63% |
| AGNG | Global X - Aging Population ETF | 2.59% |
| ABOT | Abacus FCF Innovation Leaders ETF | 2.56% |
| DHS | WisdomTree U.S. High Dividend Fund | 2.49% |
| USCF | Themes US Cash Flow Champions ETF | 2.48% |
| RYJ | Invesco Raymond James SB-1 Equity ETF | 2.45% |
| UPGD | Invesco Bloomberg Analyst Rating Improvers ETF | 2.45% |
| MOTG | VanEck Morningstar Global Wide Moat ETF | 2.42% |
| PEY | Invesco High Yield Equity Dividend Achievers ETF | 2.40% |
| LVOL | American Century Low Volatility ETF | 2.37% |
| FLOW | Global X - U.S. Cash Flow Kings 100 ETF | 2.31% |
| XPH | State Street SPDR S&P Pharmaceuticals ETF | 2.28% |
| DIVG | Invesco S&P 500 High Dividend Growers ETF | 2.24% |
| XLV | State Street Health Care Select Sector SPDR ETF | 2.21% |
| HRTS | Tema Cardiovascular and Metabolic ETF | 2.17% |
| IYH | iShares U.S. Healthcare ETF | 2.15% |
| SDOG | ALPS Sector Dividend Dogs ETF | 2.14% |
| LGCF | Themes US Cash Flow Champions ETF | 2.13% |
| SPHD | Invesco S&P 500 High Dividend Low Volatility ETF | 2.10% |
| INVN | Alger Russell Innovation ETF | 2.08% |
| VLLU | Harbor AlphaEdge Large Cap Value ETF (VLLU) | 2.07% |
| COWZ | Pacer US Cash Cows 100 ETF | 2.06% |
| GCOW | Pacer Global Cash Cows Dividend ETF | 2.03% |
| DSTL | Distillate U.S. Fundamental Stability & Value ETF | 2.02% |
| JHMH | John Hancock Multifactor Health Care ETF | 2.00% |
| BEDY | BNY Mellon Enhanced Dividend and Income ETF | 1.99% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 1.98% |
Page 1 of 9Next
About BMY ETF Exposure
Bristol-Myers Squibb Company (BMY) is held by 434 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 120.7B, BMY is a widely held institutional stock. The stock currently trades at $59.27. Investors can gain exposure to BMY through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold BMY, sorted by portfolio weight.